Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
23
PBDIF Quote, Financials, Valuation and Earnings
Last price:
$0.31
Seasonality move
:
0%
Day range:
$0.31 - $0.31
52-week range:
$0.31 - $0.31
Dividend yield:
2.17%
P/E ratio:
15.11x
P/S ratio:
2.41x
P/B ratio:
0.97x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$3B
Revenue:
$1.3B
EPS (TTM):
$0.02
Earnings Data
Next earnings date for PBDIF
--
Most recent earnings per share
$0.01
Beat by $0.01
(Dec 31/2024)
Consensus Estimate
--
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PBDIF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | $313.1M | $0.01 | -- | -- |
| 09/30/2024 | Q3 | -- | $319.2M | $0.01 | -- | -- |
| 06/30/2024 | Q2 | -- | $310M | $0.00 | -- | -- |
| 03/31/2024 | Q1 | -- | $313.7M | $0.01 | -- | -- |
| 12/31/2023 | Q4 | -- | $328.5M | $0.01 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | $0.01 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.00 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.00 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.01 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $0.01 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.01 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $0.01 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | $0.00 | -- | -- |
PT Bank Danamon Indonesia Tbk Earnings Questions
-
How Much did PT Bank Danamon Indonesia Tbk Generate in Revenue Last Quarter?
PT Bank Danamon Indonesia Tbk reported $313.1M worth of top line sales in its most recent quarter.
-
Did PT Bank Danamon Indonesia Tbk Beat Earnings Last Quarter?
PT Bank Danamon Indonesia Tbk announced earnings per share of $0.01 which represents a beat of analyst forecast a -- per share.
-
Is PT Bank Danamon Indonesia Tbk Profitable?
PT Bank Danamon Indonesia Tbk reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for PT Bank Danamon Indonesia Tbk EPS Next Year?
PT Bank Danamon Indonesia Tbk's earnings are forecast to grow from $0.02 per share to -- per share next year representing an increase of --.
-
When is PT Bank Danamon Indonesia Tbk's Earnings Date?
Currently, PT Bank Danamon Indonesia Tbk has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on July 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 6.05% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 2.4% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 4.19% over the past day.
